Beijing Strong Biotechnologies,Inc. (SHE:300406)

SHE:300406 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,062	1,043	724.04	340.72	382.52	577.19
Short-Term Investments	-	88.4	152.2	325.33	10.01	20
Trading Asset Securities	-	-	-	-	-	5.15
Cash & Short-Term Investments	1,062	1,131	876.24	666.05	392.53	602.33
Cash Growth	2.71%	29.08%	31.56%	69.68%	-34.83%	166.91%
Accounts Receivable	1,119	1,165	1,198	1,039	948.99	770.28
Other Receivables	17.34	14.47	7.9	84.84	103.76	81.29
Receivables	1,136	1,179	1,206	1,124	1,053	851.56
Inventory	231.88	220.68	229.74	219.65	252.01	247.44
Other Current Assets	158.17	50.27	22.5	56.93	43.65	71
Total Current Assets	2,588	2,581	2,334	2,067	1,741	1,772
Property, Plant & Equipment	566.84	581.77	555.24	438.93	366.19	323.56
Long-Term Investments	59.06	597.61	472.73	300.74	397.77	75
Goodwill	1,673	1,673	1,673	1,673	1,673	1,673
Other Intangible Assets	57.6	57.08	60.49	65.83	73.84	71.89
Long-Term Accounts Receivable	4.95	6.11	26.3	14.82	33.12	20.88
Long-Term Deferred Tax Assets	48.4	48.37	45.85	37.73	31.33	20.35
Long-Term Deferred Charges	1.89	1.92	2.85	3.32	3.33	3.63
Other Long-Term Assets	631.9	28.56	5.48	12.45	0.66	3.47
Total Assets	5,631	5,575	5,176	4,613	4,320	3,964
Accounts Payable	58.27	69.29	81.71	37.65	47.14	42.29
Accrued Expenses	14.31	82.82	108.21	99.7	107.35	67.65
Short-Term Debt	0.04	0.11	-	81.04	163.46	0.12
Current Portion of Long-Term Debt	42.04	37.91	2.83	1.74	192.99	38
Current Portion of Leases	-	1.46	1.13	2.02	0.73	-
Current Income Taxes Payable	50.01	33.48	23.14	20.53	26.16	14.58
Current Unearned Revenue	27.56	20.27	18.95	20.57	19.43	20.88
Other Current Liabilities	52.63	32.79	61.13	34.69	50.35	59.12
Total Current Liabilities	244.86	278.13	297.12	297.94	607.6	242.62
Long-Term Debt	1,132	1,124	1,127	1,017	766.4	262
Long-Term Leases	5.23	5.25	4.91	1.04	0.91	-
Long-Term Unearned Revenue	27.56	28.13	16.97	18.65	20.45	22.93
Long-Term Deferred Tax Liabilities	6.78	7.13	8.45	9.82	10.98	12.65
Total Liabilities	1,417	1,442	1,454	1,344	1,406	540.2
Common Stock	588.33	588.33	588.45	588.84	588.98	589
Additional Paid-In Capital	380.85	382.47	399.95	392.12	487.69	1,158
Retained Earnings	3,167	3,084	2,668	2,203	1,873	1,526
Treasury Stock	-93.63	-93.63	-109.59	-93.07	-74.8	-75
Comprehensive Income & Other	177.49	177.52	177.3	179.98	-0.54	-0.34
Total Common Equity	4,220	4,138	3,725	3,271	2,874	3,198
Minority Interest	-5.37	-5.57	-3.04	-2.44	39	225.95
Shareholders' Equity	4,215	4,133	3,722	3,269	2,913	3,423
Total Liabilities & Equity	5,631	5,575	5,176	4,613	4,320	3,964
Total Debt	1,180	1,168	1,136	1,102	1,124	300.12
Net Cash (Debt)	-117.93	-37.2	-259.39	-436.45	-731.96	302.22
Net Cash Growth	-	-	-	-	-	113.33%
Net Cash Per Share	-0.20	-0.06	-0.44	-0.71	-1.25	0.55
Filing Date Shares Outstanding	594.7	537.79	559.57	568.93	588.98	589
Total Common Shares Outstanding	594.7	537.79	559.57	568.93	588.98	589
Working Capital	2,343	2,303	2,037	1,769	1,133	1,530
Book Value Per Share	7.10	7.70	6.66	5.75	4.88	5.43
Tangible Book Value	2,490	2,409	1,992	1,533	1,128	1,453
Tangible Book Value Per Share	4.19	4.48	3.56	2.69	1.92	2.47
Buildings	-	518.07	288.33	288.33	280.47	263.14
Machinery	-	297.51	262.57	249.98	244.43	207.49
Construction In Progress	-	-	211.03	74.8	20.08	6.2

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.